Stefano R.
- Country
- Sweden
- Department
- #4255: Kardiologens Forskningsenhet
Research Overview
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
- Evaluation of Subcutaneous ISIS 678354 Sodium Salt in Patients with Familial Chylomicronemia Syndrome: An Open-Label Extension Study
- Evaluation of Pelacarsen (TQJ230) in Reducing Major Cardiovascular Events in Patients with Established Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 277 of 472 partner sites.
Specializations
Lipid Disorders
The investigator specializes in treating severe hypertriglyceridemia (SHTG), conducting research on innovative therapeutic approaches for patients with elevated triglyceride levels.
- Triglyceride Management
- Lipid Level Control
- Metabolic Disorders
Research extends to treating rare genetic conditions like Familial Chylomicronemia Syndrome (FCS).
Cardiovascular Medicine
Focuses on advancing treatments for cardiovascular disease with particular attention to lipoprotein disorders and their impact on cardiovascular health.
- Cardiovascular Risk Management
- Preventive Cardiology
- Lipoprotein(a) Research
Investigation includes novel approaches for reducing major cardiovascular events in high-risk patients.
Therapeutic Innovation
Evaluates novel therapeutic agents including olezarsen and pelacarsen for treating various lipid disorders and cardiovascular conditions.
- Drug Safety Assessment
- Clinical Efficacy Studies
- Long-term Treatment Outcomes
Implements targeted therapeutic approaches for patients with severe metabolic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.